Risk factors and early recurrence patterns following curative-intent resection of distal cholangiocarcinoma
HPB · 2026
DOI: 10.1016/j.hpb.2025.10.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2026. Verfasst von Inhyuck Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University …. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Neoplasm Recurrence, Local, Bile Duct Neoplasms, Pancreaticoduodenectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Korea Ministry of Health and Welfare.
Abstract (Originalsprache)
BACKGROUND: Distal cholangiocarcinoma (DCC) has poor prognosis, with >50% affected patients experiencing early recurrence (ER) within 12 months after curative-intent surgery. This retrospective study analyzed ER characteristics, survival outcomes, and risk factors of DCC. METHODS: We categorized 519 patients with DCC who underwent curative-intent surgery at Seoul National University Hospital (2008-2023) into ER (n=115) and non-ER (n=404) groups. Primary endpoints were ER and overall survival (OS). We compared OS between ER and an additional non-curative reference cohort (R2/M1, n=53). Cutoffs for continuous variables were derived using the receiver operating characteristic (ROC) curve/Youden. RESULTS: Median OS and recurrence-free survival were 53.6 and 52.4 months, respectively. Independent ER predictors were preoperative CA19-9 of >70 U/mL (hazard ratio [HR], 1.58), BMI of ≤21.0 kg/m² (HR, 2.04) or >25.0 kg/m² (HR 1.81), LNR of >15% (HR, 2.01), and postoperative CA19-9 of >37 U/mL (HR, 1.71). OS was similar between ER and R2/M1 groups (16.8 vs 15.6 months; p=0.998). In subgroup analyses stratified by ER status, adjuvant chemotherapy (including 5-FU), radiotherapy, and concurrent chemoradiotherapy were not associated with improved OS. CONCLUSION: ER after curative-intent resection has outcomes comparable to non-curative disease, supporting risk-adapted staging and evaluation of neoadjuvant strategies for high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: jsp…
Förderung
- Korea Health Industry Development Institute
- Korea Ministry of Health and Welfare
Zitieren
APA
Lee, I., Seo, Y., Choi, G. W., Chae, Y. S., Yun, W. G., Han, Y., Jung, H. S., Cho, Y. J., Kwon, W., Jang, J. Y., & Park, J. S. (2026). Risk factors and early recurrence patterns following curative-intent resection of distal cholangiocarcinoma. HPB. https://doi.org/10.1016/j.hpb.2025.10.006
Vancouver
Lee I, Seo Y, Choi GW, Chae YS, Yun WG, Han Y, et al. Risk factors and early recurrence patterns following curative-intent resection of distal cholangiocarcinoma. HPB. 2026. doi:10.1016/j.hpb.2025.10.006
BibTeX
@article{Lee2026,
author = {Lee, Inhyuck and Seo, Younsoo and Choi, Go-Won and Chae, Yoon Soo and Yun, Won-Gun and Han, Youngmin and Jung, Hye-Sol and Cho, Young Jae and Kwon, Wooil and Jang, Jin-Young and Park, Joon Seong},
title = {Risk factors and early recurrence patterns following curative-intent resection of distal cholangiocarcinoma},
journal = {HPB},
year = {2026},
doi = {10.1016/j.hpb.2025.10.006}
}
EUVIMED